Ureteroscopic management of upper tract transitional cell carcinoma in patients with normal contralateral kidneys.
about
Upper tract urothelial carcinoma: Paradigm shift towards nephron sparing managementRetrograde endoscopic laser therapy for transitional cell carcinoma of the upper urinary tract.Mitomycin C instillation following ureterorenoscopic laser ablation of upper urinary tract carcinoma.The significance of functional renal obstruction in predicting pathologic stage of upper tract urothelial carcinoma.Endourological management of upper tract transitional cell carcinoma.Nephron-sparing management vs radical nephroureterectomy for low- or moderate-grade, low-stage upper tract urothelial carcinoma.Increasing dwell time of mitomycin C in the upper tract with a reverse thermosensitive polymer.Upper urinary tract transitional cell carcinoma: current treatment overview of minimally invasive approaches.Comprehensive management of upper tract urothelial carcinomaEndourologic management of upper tract transitional cell carcinoma following cystectomy and urinary diversion.Endoscopic management of upper tract urothelial carcinoma.Conservative management of upper tract transitional cell carcinomaRisk-adapted strategy for the kidney-sparing management of upper tract tumours.Induction and Maintenance Adjuvant Mitomycin C Topical Therapy for Upper Tract Urothelial Carcinoma: Tolerability and Intermediate Term Outcomes.Impact of Ureteroscopy Before Nephroureterectomy for Upper Tract Urothelial Carcinoma on Oncologic Outcomes.Canadian guidelines for postoperative surveillance of upper urinary tract urothelial carcinoma.
P2860
Q28066806-82600C48-B3C2-453C-BB48-AF57D5F28E52Q30951748-9C456CEE-3853-459E-B1CA-04B9EECC961DQ34992162-FD5CB926-2CEE-46BD-AC81-ED8B06A98E4BQ35428883-0F5D44B6-0E69-49AF-914B-AD2D09A88171Q35591101-513E67B7-AD2C-4177-9BE7-DA5D69B018A9Q35801387-57D1AE77-E22B-474A-8B14-B11221B42387Q36672424-EC619F5E-C793-443C-A61C-CD32EA337C04Q36793132-02CDBB65-6730-4E41-ABA2-4FC1BFF54348Q37354858-02473B26-D759-49A3-A126-1C81C84B7694Q37363073-D7D769CF-347D-426C-8B8B-30E946095152Q37365204-E7A09006-1CB3-4A16-BB8A-09CFDFA59CD1Q37495463-10C7B6BA-D919-4CF5-B8CD-7707C4E8B5E9Q38364579-8AE46172-743B-4971-8EF9-16B9100E9BC4Q38668080-EAFFACF8-C4EF-44AB-B3A5-5DB52CB248C5Q38847571-4AD35A8F-1724-4B7A-92FF-A3222EB41A04Q42838843-CA69BE26-48BE-49E2-9366-4CB0CC353610
P2860
Ureteroscopic management of upper tract transitional cell carcinoma in patients with normal contralateral kidneys.
description
2000 nî lūn-bûn
@nan
2000 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Ureteroscopic management of up ...... normal contralateral kidneys.
@ast
Ureteroscopic management of up ...... normal contralateral kidneys.
@en
type
label
Ureteroscopic management of up ...... normal contralateral kidneys.
@ast
Ureteroscopic management of up ...... normal contralateral kidneys.
@en
prefLabel
Ureteroscopic management of up ...... normal contralateral kidneys.
@ast
Ureteroscopic management of up ...... normal contralateral kidneys.
@en
P1476
Ureteroscopic management of up ...... normal contralateral kidneys.
@en
P2093
P304
P356
10.1097/00005392-200010000-00010
P407
P577
2000-10-01T00:00:00Z